Colorectal cancer and the liver

Annals of the Royal College of Surgeons of England

Volumn 79, Issue 5, 1997, Pages 315-318

  Taylor, Irving ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Colorectal cancer; Liver; Metastases

Indexed keywords

ADJUVANT THERAPY; COLORECTAL CANCER; INFUSION; LARGE INTESTINE; LIVER; LIVER METASTASIS; METASTASIS INHIBITION; PORTAL VEIN; SHORT SURVEY;

ANIMALS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; RATS;

EID: 0030774620     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (29)

1. Wynder EL, Reddy BS. Dietary fat and colon cancer. J Natl Cancer Inst 1975; 54: 7-10.
2. Hill MJ, Aries V. Faecal steroid composition and its relationship to cancer of the large bowel. J Pathol 1971; 104: 129-39.
3. Summerton J, Flynn M, Cooke T, Taylor I. Bile acid receptors in colorectal cancer. Br J Surg 1983; 70: 549-51.
4. Taylor I. Studies on the treatment and prevention of colorectal liver metastases. Ann R Coll Surg Engl 1981; 63: 270-76.
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1985; 1: 27-31.
6. Murphy P, Alexander P, Kirkham N, Fleming J, Taylor I. Pattern of spread of blood borne tumour. Br J Surg 1986; 73: 829-36.
7. Mooney B, Grime JS, Taylor I, Critchley M. Portal scanning for liver metastases in colorectal cancer. Clin Radiol 1983; 34: 657-9.
8. Leen E, Goldberg JA, Anderson JR. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993; 34: 554-7.
9. Leen E, Goldberg JA, Robertson J et al. Early detection of occult colorectal hepatic metastases using duplex colour doppler sonography. Br J Surg 1993; 80: 1249-51.
10. Murphy P, Alexander P, Senior PV, Fleming J, Kirkham N, Taylor I. Mechanisms of organ selective tumour growth by blood borne cancer cells. Br J Cancer 1988; 57: 19-31.
11. Loizidou M, Lawrence RJ, Holt S et al. Facilitation by partial hepatectomy of tumour growth within the rat liver following intrahepatic injection of syngeneic tumour cells. Clin Exp Metastasis 1991; 9: 335-50.
12. Ashraf S, Loizidou M, Crowe R, Turmaine M, Taylor I, Burnstock G. The absence of autonomic perivascular nerves in human colorectal liver metastases. Br J Cancer 1996; 73: 349-59.
13. Hemingway DM, Cooke TG, Chang D et al. The effects of intra-arterial vasoconstrictors on the distribution of a radio-labelled low molecular weight marker in an experimental model of liver tumour. Br J Cancer 1991; 63: 495-8.
14. Shankar A, Loizidou M, Frederick S et al. Endothelin-1 production and secretion by colorectal cancer. Br J Surg 1996; 83: 1628.
15. Moertel C, Fleming TR, Macdonald JS et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
16. Wolmark N, Rockette H, Fisher B et al. The benefit of leucovorin modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993; 11: 1879-87.
17. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345:939-44.
18. MRC Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operative locally advanced rectal cancer. Lancet 1996; 348: 1605-9.
19. MRC Rectal Cancer Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet 1996; 348: 1610-14.
20. Taylor I, Machin D, Mullee M, Trotter G, Cooke T, West C. A randomised controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 1985; 72: 359-63.
21. Piedbois P, Buyse M, Gray R et al. Portal vein infusion is an effective adjuvant treatment for patients with colorectal cancer. Proc Am Soc Clin Oncol 1995; 14: 192.
22. Buyse M, Zelenuich-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA 1988; 259: 3571-8.
23. Scheele J, Stang R, Aldendorf-Hofman A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
24. Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T, Takayama T. Pattern of recurrence after hepatic resection for colorectal metastases. World J Surg 1993; 80: 1032-5.
25. Scott S, Carty N, Anderson L, Taylor I. Liver resection for colorectal liver metastases. Eur J Surg Oncol 1995; 21: 33-5.
26. Hunt TM, Flowerdew ADS, Birch SJ, Williams JD, Mullee M, Taylor I. Prospective randomised controlled trial of hepatic arterial embolisation or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 1990; 77: 779-82.
27. Hind R, Loizidou M, Perring S et al. Biodistribution of lipiodol following hepatic artery injection. Br J Surg 1992; 79: 952-4.
28. Kerr DJ, Ledermann JA, McArdle CS et al. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil. J Clin Oncol 1995; 13: 2968-72.
29. Seymour MT, Slevin ML, Kerr DJ et al. Randomised trial assessing the addition of interferon to fluorouracil and leucovorin in advanced colorectal cancer. J Clin Oncol 1996; 14, 2280-88.